Search results
Q1 2024 Humacyte Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoResults from ongoing preclinical studies support the potential of our bio vascular pancreas, or BVP, which is a product candidate to enable the delivery and survival of insulin producing islets ...
1 in 8 adults have taken a GLP-1: 5 notes
Becker’s Hospital Review· 6 days agoOne in 8, or 12% of adults said they have taken GLP-1s and 6% of adults said they currently take the drugs, KFF Health reported May 10. The KFF Health Tracking Poll surveyed 1,479 adults online ...
Coronary Artery Disease: The New Big C
Medscape· 1 day agoToday, we're going to talk to a colleague from Stanford who has written a new book on heart disease and cancer. McConnell: Great to be here. Harrington:...
One in 8 US adults have now used meds like Ozempic, finds poll
Medical Xpress· 6 days agoMost patients say they use the drugs (61%) to treat a chronic condition like diabetes or heart...
Experts Share Tips And Tools For Protecting Brain Health In Menopause
Forbes· 3 days agoMenopause is diagnosed after someone has gone 12 months without a menstrual period. Literally every...
One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic
US News & World Report· 6 days agoMost patients say they use the drugs (61%) to treat a chronic condition like diabetes or heart disease, which can make it easier to obtain a prescription, the report says.
Opinion: Southwest YMCA supports health and well-being for all
San Jose Mercury News· 4 days agoIn this month’s column, I’m excited to shine a spotlight on local community programs that make a...
Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoHumacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript May 12, 2024 Humacyte, Inc. isn’t one...
Poll: 1 in 8 U.S. adults have tried weight-loss drugs like Wegovy, Ozempic - UPI.com
UPI· 6 days agoMost patients say they use the drugs (61%) to treat a chronic condition like diabetes or heart...
Abbott’s Jennifer Jones-McMeans on treating PAD below the knee
MedTech Dive via Yahoo Finance· 7 days agoJennifer Jones-McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved...
